Latest revenue
$5.32B
as of 2026-03-31
Latest net income
$646.0M
as of 2026-03-31
Net margin
12.1%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $72.51B
- Enterprise value
- $81.34B
- P/E (trailing)
- 34.0×
- Forward P/E
- —
- P/B
- 84.70×
- Dividend yield
- 2.3%
- 52-wk high
- $99.33
- 52-wk low
- $74.55
- Beta
- —
- Shares out
- 800.2M
5-year trend
What this company does
PART I ITEM 1. BUSINESS General Development of the Business Colgate-Palmolive Company (together with its subsidiaries, “we,” “us,” “our,” the “Company” or “Colgate-Palmolive”) is a caring, innovative growth company united behind our purpose to reimagine a healthier future for all people, their pets and our planet. To achieve our business and financial objectives and deliver peer-leading performance and total shareholder return, we are focused on driving organic sales growth; delivering consistent, compounded earnings per share growth; achieving operational efficiencies; and driving growth in free cash flow along with the efficient use of our balance sheet. We do this by leveraging the…
AI summary unavailable — showing raw filing excerpt
Generated from CL's filing dated 2026-02-23
Key risks
ITEM 1A. RISK FACTORS In addition to the risks described elsewhere in this report, set forth below is a summary of the material risks to an investment in our securities. These risks, some of which have occurred and/or are occurring and any of which could occur in the future, are not the only ones we face. Additional risks not presently known to us or that we currently deem immaterial may also have an adverse effect on us. To the extent any of these risks actually occur, our business, results of operations, cash flows and financial condition could be materially and adversely impacted, which might cause the value of our securities to decline. Business and Industry Risks We face risks…
AI summary unavailable — showing raw filing excerpt
Generated from CL's filing dated 2026-02-23
Profitability
Gross margin
60.1%
0.6%Operating margin
16.2%
23.6%Net margin
10.5%
27.2%Return on equity
3948.1%
189.7%Return on assets
13.1%
27.5%Leverage
Debt / equity
301.41×
303.6%Long-term debt / equity
127.24×
270.1%Debt / assets
99.7%
1.0%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $5.32B | +8.4% | $646.0M | -6.4% | 12.1% |
Q4 2025 2025-12-31 | $5.23B | +5.8% | $-36.0M | -104.9% | -0.7% |
Q3 2025 2025-09-30 | $5.13B | +1.9% | $735.0M | -0.3% | 14.3% |
Q2 2025 2025-06-30 | $5.11B | +1.0% | $743.0M | +1.6% | 14.5% |
Q1 2025 2025-03-31 | $4.91B | -3.0% | $690.0M | +1.0% | 14.1% |
Q4 2024 2024-12-31 | $4.95B | — | $738.0M | — | 14.9% |
Q3 2024 2024-09-30 | $5.03B | +2.4% | $737.0M | +4.1% | 14.6% |
Q2 2024 2024-06-30 | $5.06B | +4.9% | $731.0M | +45.6% | 14.5% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Perfumes, Cosmetics & Other Toilet Preparations · SIC 2844
Your notes
Keep private notes on CL — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$26.1M
Net activity
−$26.1M
Distinct insiders
7
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns CL
Institutional value
$20.08B
Total shares held
240.2M
Distinct holders
747
As of
2026-03-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 52.2M | $4.45B | — | New |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 23.8M | $2.03B | — | New |
| 3 | Bank of New York Mellon Corp | 12.5M | $1.07B | — | New |
| 4 | DEUTSCHE BANK AG\ | 11.9M | $1.02B | — | New |
| 5 | Invesco Ltd. | 8.3M | $710.7M | — | New |
| 6 | First Eagle Investment Management, LLC | 8.1M | $691.8M | — | New |
| 7 | Legal & General Group Plc | 5.7M | $487.3M | — | New |
| 8 | DIAMOND HILL CAPITAL MANAGEMENT INC | 5.4M | $460.8M | — | New |
| 9 | DIMENSIONAL FUND ADVISORS LP | 5.2M | $442.3M | — | New |
| 10 | STIFEL FINANCIAL CORP | 5.0M | $423.3M | — | New |
| 11 | UBS Group AG | 4.6M | $393.3M | — | New |
| 12 | VANGUARD FIDUCIARY TRUST CO | 4.6M | $390.8M | — | New |
| 13 | WELLS FARGO & COMPANY/MN | 4.1M | $351.6M | — | New |
| 14 | Swedbank AB | 4.0M | $337.8M | — | New |
| 15 | TD ASSET MANAGEMENT INC | 3.6M | $304.6M | — | New |
| 16 | National Pension Service | 2.3M | $198.2M | — | New |
| 17 | Swiss National Bank | 2.2M | $191.5M | — | New |
| 18 | Nuveen, LLC | 2.1M | $180.9M | — | New |
| 19 | BNP PARIBAS FINANCIAL MARKETS | 2.0M | $168.5M | — | New |
| 20 | Mitsubishi UFJ Asset Management Co., Ltd. | 1.9M | $164.0M | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once CL's latest filing finishes processing.